Literature DB >> 28886918

Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review.

Xiao-Min Xu1, Yang Liu1, Shi-Yu Jia1, Mei-Xue Dong1, Du Cao1, You-Dong Wei2.   

Abstract

Restless legs syndrome (RLS) is defined as an irresistible urge to move the legs, which is usually accompanied by paresthesias or dysesthesias at least twice weekly, and affects 2%-4% of adults in Europe and North America. This systematic review assesses the current complementary and alternative options for RLS and the potential benefits of those treatments on sleep quality, mood disorder, and quality of life. A systematic search of the PubMed, Embase, Cochrane, and Web of Science databases was conducted. Eighteen studies met the inclusion criterion, which included the use of the international RLS study group criteria. Complementary and alternative therapies have been found to be effective in both primary and secondary RLS. The severity of primary RLS symptoms can be significantly ameliorated by exercise training, transcutaneous spinal direct current stimulation, pneumatic compression devices, light therapy, repetitive transcranial magnetic stimulation, and acupuncture. Pneumatic compression devices and yoga also improve RLS-related disorders. Exercise training is highly efficacious in the reduction of symptom severity in uremic RLS and related effects such as poor quality of life. Endovenous laser ablation may be a good choice for patients with concurrent RLS and superficial venous insufficiency.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complementary and alternative therapies; Depression; Periodic limb movements; Quality of life; Restless legs syndrome (RLS); Sleep; Uremic

Mesh:

Year:  2017        PMID: 28886918     DOI: 10.1016/j.smrv.2017.06.003

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  7 in total

1.  Clinical Efficacy and Safety of Massage for the Treatment of Restless Leg Syndrome in Hemodialysis Patients: A Meta-Analysis of 5 Randomized Controlled Trials.

Authors:  Min Xia; Qien He; Guanghui Ying; Xiapei Fei; Wenjing Zhou; Xuelin He
Journal:  Front Psychiatry       Date:  2022-04-11       Impact factor: 5.435

Review 2.  Physical activity and sleep: An updated umbrella review of the 2018 Physical Activity Guidelines Advisory Committee report.

Authors:  Christopher E Kline; Charles H Hillman; Bonny Bloodgood Sheppard; Bethany Tennant; David E Conroy; Richard F Macko; David X Marquez; Steven J Petruzzello; Kenneth E Powell; Kirk I Erickson
Journal:  Sleep Med Rev       Date:  2021-04-09       Impact factor: 11.401

3.  Acupuncture point injection markedly improved sensory symptoms and motor signs in 2 patients with restless legs syndrome.

Authors:  Takero Fukutome
Journal:  Clin Case Rep       Date:  2018-05-31

Review 4.  Restless Legs Syndrome across the Lifespan: Symptoms, Pathophysiology, Management and Daily Life Impact of the Different Patterns of Disease Presentation.

Authors:  Giuseppe Didato; Roberta Di Giacomo; Giuseppa Jolanda Rosa; Ambra Dominese; Marco de Curtis; Paola Lanteri
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

5.  Traditional Chinese Medicine for Post-stroke Sleep Disorders: The Evidence Mapping of Clinical Studies.

Authors:  Qing Su; Danmei Zou; Nuo Gai; Huishan Li; Zhuoran Kuang; Xiaojia Ni
Journal:  Front Psychiatry       Date:  2022-06-15       Impact factor: 5.435

6.  Effect of electroacupuncture on restless legs syndrome (RLS) in hemodialysis patients: A protocol for systematic review and meta-analysis.

Authors:  Jia-Ming Chen; Ping-Fang Chiu; Yu-Jun Chang; Po-Chi Hsu; Chia-Chu Chang; Lun-Chien Lo
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

Review 7.  Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review).

Authors:  Andrei Vlasie; Simona Corina Trifu; Cristiana Lupuleac; Bianca Kohn; Mihai Bogdan Cristea
Journal:  Exp Ther Med       Date:  2021-12-30       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.